sleep apnoea

News

Sleep apnoea drug firm Apnimed files for IPO

Apnimed has joined the IPO queue on the Nasdaq, hoping to raise additional funding for its late-stage oral therapy for obstructive sleep apnoea.

News

Basketball great Shaq fronts Lilly sleep apnoea campaign

Eli Lilly has recruited basketball legend Shaquille O'Neal to promote a sleep apnoea awareness campaign and make the case for treatment with Zepbound.

News

Patient using a positive airway pressure mask

Lilly grabs first-ever FDA nod for a sleep apnoea drug

Lilly's Zepbound has become the first drug approved by the FDA for obese patients with obstructive sleep apnoea, which affects millions in the US.

News

FDA clears sleep apnoea feature for new Apple Watch

Apple has the FDA authorisation it needs to bring its software for detecting sleep apnoea to the Apple Watch, coinciding with the launch of its new operating system for the wearable.

News

Home testing devices for sleep apnoea backed for NHS use

Five home-testing devices for obstructive sleep apnoea hypopnoea syndrome (OSAHS), a potentially dangerous condition affecting 2.5 million adults in the UK, have been reco

News

Trials set up filing for Lilly’s tirzepatide in sleep apnoea

Eli Lilly’s diabetes and obesity therapy tirzepatide could find a use as a treatment for obstructive sleep apnoea (OSA) after hitting the mark in a pair of phase 3 trials.

Sleep apnoea drug firm Apnimed files for IPO

Basketball great Shaq fronts Lilly sleep apnoea campaign

Lilly grabs first-ever FDA nod for a sleep apnoea drug

FDA clears sleep apnoea feature for new Apple Watch

Home testing devices for sleep apnoea backed for NHS use

Trials set up filing for Lilly’s tirzepatide in sleep apnoea

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

sleep apnoea

Editor's Picks